BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1215 related articles for article (PubMed ID: 16996762)

  • 1. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Fetal Diagn Ther; 2008; 23(3):211-6. PubMed ID: 18417980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
    Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR.
    Baviera G; D'Anna R; Corrado F; Ruello A; Buemi M; Jasonni VM
    J Reprod Med; 2002 Mar; 47(3):191-3. PubMed ID: 11933682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction.
    Van Eerden P; Wu XX; Chazotte C; Rand JH
    Am J Obstet Gynecol; 2006 May; 194(5):1371-6. PubMed ID: 16579937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
    Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
    Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors.
    Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM
    Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
    Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
    Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.
    D'Anna R; Baviera G; Cannata ML; De Vivo A; Di Benedetto A; Corrado F
    Gynecol Obstet Invest; 2007; 64(2):65-8. PubMed ID: 17264515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum placental growth hormone at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
    Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1796-9. PubMed ID: 22489624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
    Adachi T; Nakabayashi M; Sakura M; Ando K
    Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second trimester amniotic fluid endothelin-1 concentrations and subsequent development of intrauterine growth restriction.
    Margarit L; Griffiths AN; Tsapanos V; Tsakas S; Gumenos D; Decavalas G
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):192-5. PubMed ID: 17123690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.